TREATMENT OF OSTEOPOROSIS – ‘When to start, when to stop and when to change?’
30th November 2017, NEC Birmingham
With a brand new and innovative format this event promises to provide multidisciplinary clinicians in England with the opportunity to discuss the treatment and management of osteoporosis. The Clinical Update will bring a series of interactive clinical case discussions to you, presented as part of an expert discussion panel. You can expect to hear and participate in lively debate around identifying the high-risk patient, treatment options for the atypical patient and considerations for duration of treatment.…
Read more of this article


On the 26th May 2017, the British Society for Rheumatology released an important update to their most ‘in demand’ clinical guideline, on the Management of Gout. Gout is the most searched for term on the BSR website and it’s is a particularly painful form of arthritis which is becoming more common, yet continues to be poorly managed.
Guest Blog by Neil Betteridge, co-chair, Chronic Pain Policy Coalition (CPPC)
15-18 February 2018
Did you miss getting to the Rheumatology Conferences in 2016?

On Monday 8th May 2017 the Scottish Medicines Consortium (SMC) published new advice accepting the restricted use of belimumab (Benlysta) by NHS Scotland for lupus patients. This advice was published following a re-submission with evidence supplied by GlaxoSmithKline (the producers of Benlysta) and LUPUS UK on behalf of patients.